Thursday, May 7, 2026
Today's Print

Tag: Mathai Mammen

Johnson & Johnson COVID-19 vaccine candidate demonstrates robust protection in pre-clinical studies

Johnson & Johnson announced that its lead vaccine candidate for COVID-19 elicited a robust immune response as demonstrated by “neutralizing antibodies” in pre-clinical studies. The...
- Advertisement -spot_img
- Advertisement -spot_img